Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer-Reference-Cited by-同舟云学术

Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer

Published:2017-02-10 Issue:6 Volume:109 Page:
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Kawakami Masanori¹,Mustachio Lisa Maria¹,Rodriguez-Canales Jaime¹,Mino Barbara¹,Roszik Jason¹,Tong Pan¹,Wang Jing¹,Lee J. Jack¹,Myung Ja Hye¹,Heymach John V.¹,Johnson Faye M.¹,Hong Seungpyo¹,Zheng Lin¹,Hu Shanhu¹,Villalobos Pamela Andrea¹,Behrens Carmen¹,Wistuba Ignacio¹,Freemantle Sarah¹,Liu Xi¹,Dmitrovsky Ethan¹

Affiliation:

1. Affiliations of authors: Departments of Thoracic/Head and Neck Medical Oncology (MK, LMM, JVH, FMJ, LZ, CB, XL, ED), Translational Molecular Pathology (JRC, BM, PAV, IW), Melanoma Medical Oncology (JR), Genomic Medicine (JR), Bioinformatics and Computational Biology (PT, JW), Biostatistics (JJL), Cancer Biology (JVH, ED), The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Biopharmaceutical Sci

Funder

National Institutes of Health(NIH)

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/109/6/djw297/25422341/djw297.pdf

Reference42 articles.

1. Global trends of lung cancer mortality and smoking prevalence;Islami;Transl Lung Cancer Res.,2015

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin.,2015